本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagenic Therapeutics, Inc.

0.5200
-0.2300-30.67%
成交量:1,220.00
成交額:708.96
市值:100.61萬
市盈率:-0.10
高:0.7400
開:0.6850
低:0.5200
收:0.7500
52周最高:14.28
52周最低:0.2500
股本:193.49萬
流通股本:191.49萬
量比:0.24
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-5.3030
每股收益(LYR):-15.7868
淨資產收益率:-512.79%
總資產收益率:-189.60%
市淨率:-11.39
市盈率(LYR):-0.03

資料載入中...

2021/04/30

重要事件披露

8-K - Current report
2021/04/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/23

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/21

重要事件披露

8-K - Current report
2021/04/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/08

重要事件披露

8-K - Current report
2021/04/07

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/11

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/07

重要事件披露

8-K - Current report